Literature DB >> 16099803

Chronic intestinal pseudo-obstruction due to lymphocytic leiomyositis: is there a place for immunomodulatory therapy?

E Oton, V Moreira, C Redondo, A Lopez-San-Roman, J R Foruny, G Plaza, E de Vicente, Y Quijano.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16099803      PMCID: PMC1774639          DOI: 10.1136/gut.2005.071811

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  8 in total

1.  Dilated stomach and weak muscles.

Authors:  S P Rigby; J M Schott; P Bliss; C S Higgens; M A Kamm
Journal:  Lancet       Date:  2000-12-02       Impact factor: 79.321

Review 2.  Advances in our understanding of the pathology of chronic intestinal pseudo-obstruction.

Authors:  R De Giorgio; G Sarnelli; R Corinaldesi; V Stanghellini
Journal:  Gut       Date:  2004-11       Impact factor: 23.059

3.  Acquired myopathic intestinal pseudo-obstruction may be due to autoimmune enteric leiomyositis.

Authors:  Tarja H Ruuska; Riitta Karikoski; Virpi V Smith; Peter J Milla
Journal:  Gastroenterology       Date:  2002-04       Impact factor: 22.682

4.  Clinical characteristics of chronic idiopathic intestinal pseudo-obstruction in adults.

Authors:  S D Mann; H S Debinski; M A Kamm
Journal:  Gut       Date:  1997-11       Impact factor: 23.059

5.  A curable cause of chronic idiopathic intestinal pseudo-obstruction in children: idiopathic myositis of the small intestine.

Authors:  J L Giniès; H François; M G Joseph; G Champion; L Coupris; J M Limal
Journal:  J Pediatr Gastroenterol Nutr       Date:  1996-11       Impact factor: 2.839

6.  Diffuse lymphoplasmacytic infiltration of the small intestine with damage to nerve plexus. A cause of intestinal pseudo-obstruction.

Authors:  J Arista-Nasr; M González-Romo; C Keirns; J Larriva-Sahd
Journal:  Arch Pathol Lab Med       Date:  1993-08       Impact factor: 5.534

7.  [Idiopathic myositis of the small intestine. An unusual cause of chronic intestinal pseudo-obstruction in children].

Authors:  C Nezelof; E Vivien; P Bigel; C Nihoul-Fekete; F Arnaud-Battandier; J L Bresson; P Arhan; C Ricour
Journal:  Arch Fr Pediatr       Date:  1985-12

8.  Intestinal pseudoobstruction caused by diffuse lymphoid infiltration of the small intestine.

Authors:  G B McDonald; M D Schuffler; M E Kadin; G N Tytgat
Journal:  Gastroenterology       Date:  1985-10       Impact factor: 22.682

  8 in total
  7 in total

1.  A novel approach to paraneoplastic intestinal pseudo-obstruction.

Authors:  Ambuga Badari; Deborah Farolino; Eiad Nasser; Shahid Mehboob; David Crossland
Journal:  Support Care Cancer       Date:  2011-11-10       Impact factor: 3.603

2.  Chronic intestinal pseudo-obstruction due to lymphocytic intestinal leiomyositis: Case report and literature review.

Authors:  Keiichi Uchida; Kohei Otake; Mikihiro Inoue; Yuhki Koike; Kohei Matsushita; Toshimitsu Araki; Yoshiki Okita; Koji Tanaka; Katsunori Uchida; Noriko Yodoya; Shotaro Iwamoto; Katsuhiro Arai; Masato Kusunoki
Journal:  Intractable Rare Dis Res       Date:  2012-02

Review 3.  Chronic Intestinal Pseudo-obstruction.

Authors:  Khalil El-Chammas; Manu R Sood
Journal:  Clin Colon Rectal Surg       Date:  2018-02-25

Review 4.  Recent Advances in the Management of Severe Gastrointestinal Dysmotility.

Authors:  Dipesh H Vasant; Simon Lal
Journal:  Clin Exp Gastroenterol       Date:  2021-05-10

5.  Autoimmune Gastrointestinal Paralysis: Failure of Conventional Treatment without Immunomodulation.

Authors:  Craig Weinkauf; Sean McPhillips; Robert Krouse; Ira Levine
Journal:  Case Rep Surg       Date:  2014-09-18

6.  The management of adult patients with severe chronic small intestinal dysmotility.

Authors:  Jeremy M D Nightingale; Peter Paine; John McLaughlin; Anton Emmanuel; Joanne E Martin; Simon Lal
Journal:  Gut       Date:  2020-08-21       Impact factor: 23.059

Review 7.  Latest developments in chronic intestinal pseudo-obstruction.

Authors:  Chang-Zhen Zhu; Hong-Wei Zhao; Hong-Wei Lin; Feng Wang; Yuan-Xin Li
Journal:  World J Clin Cases       Date:  2020-12-06       Impact factor: 1.337

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.